Related Experiment Video

Updated: Jul 29, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[use of a Staphylococcus bacterial vaccine in pediatric patients with chronic sinusitis]

A Martínez Pérez1, M T Chavarría Jiménez, A J Miranda Feria

  • 1Unidad de pediatría, Hospital General de México.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|May 8, 1999
PubMed

Insights

Bacterial vaccines containing Staphylococcus aureus antigens show promise in treating pediatric chronic sinusitis. This study found that 82% of young patients improved, with significant increases in immunoglobulin levels.

Area of Science:

  • Immunology
  • Otolaryngology
  • Pediatrics

Background:

  • Bacterial vaccine antigenic extracts, specifically from Staphylococcus aureus, are known to enhance phagocytosis, boost immunoglobulin levels, and support the immune response.
  • Chronic sinusitis is a common condition in children, often requiring long-term management.

Purpose of the Study:

  • To evaluate the efficacy of a bacterial vaccine in pediatric patients diagnosed with chronic sinusitis.

Main Methods:

  • A prospective, observational, longitudinal study involved 50 pediatric patients with chronic sinusitis.
  • Patients received subcutaneous bacterial vaccine injections over eight months, with a six-month follow-up.
  • Immunoglobulin levels and blood/nasal cytology were monitored throughout the study.

Main Results:

  • A significant improvement was observed in 82% of the patients treated with the bacterial vaccine.
  • Elevated levels of Immunoglobulin A (IgA) and Immunoglobulin G (IgG) were noted in 76% of the participants.
  • While most patients improved, 18% continued to experience symptoms, with some requiring further medical or surgical intervention.

Conclusions:

  • The bacterial vaccine demonstrates considerable effectiveness in managing chronic sinusitis in pediatric populations.
  • The observed increase in IgA and IgG suggests the vaccine bolsters humoral immunity, contributing to clinical improvement.
  • Further research may explore optimizing vaccine protocols and identifying patient subgroups that benefit most.
Abstract

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...